Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trialcoroniavaughns@kbin.social to Science@kbin.social – 1 points – 1 years agothelancet.com0Post a CommentPreviewHotTopNewOldNo comments yet. You could be first!